John Staczek

1.2k total citations
34 papers, 981 citations indexed

About

John Staczek is a scholar working on Epidemiology, Oncology and Molecular Biology. According to data from OpenAlex, John Staczek has authored 34 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 10 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in John Staczek's work include Herpesvirus Infections and Treatments (16 papers), Cytomegalovirus and herpesvirus research (14 papers) and Viral-associated cancers and disorders (10 papers). John Staczek is often cited by papers focused on Herpesvirus Infections and Treatments (16 papers), Cytomegalovirus and herpesvirus research (14 papers) and Viral-associated cancers and disorders (10 papers). John Staczek collaborates with scholars based in United States, Germany and Switzerland. John Staczek's co-authors include Dennis J. O’Callaghan, Raymond P. Baumann, H. E. Gilleland, Linda B. Gilleland, Gretchen B. Caughman, Wayne L. Gray, Alice Robertson, Frank R. Brennan, W D Hamilton and Roger N. Beachy and has published in prestigious journals such as Journal of Virology, Infection and Immunity and Virology.

In The Last Decade

John Staczek

33 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Staczek United States 19 574 273 220 163 143 34 981
Sylvie Laurent France 16 296 0.5× 256 0.9× 74 0.3× 55 0.3× 81 0.6× 35 1.1k
Ruth Serra-Moreno United States 16 399 0.7× 257 0.9× 314 1.4× 22 0.1× 370 2.6× 27 1.3k
P A Hoyne Australia 15 254 0.4× 347 1.3× 77 0.3× 16 0.1× 124 0.9× 18 796
D. M. A. Evans United Kingdom 13 290 0.5× 467 1.7× 72 0.3× 15 0.1× 158 1.1× 18 1.6k
Ieva Kotlarski Australia 17 161 0.3× 116 0.4× 239 1.1× 68 0.4× 106 0.7× 54 774
Ruth Ann Scroggs United States 18 799 1.4× 189 0.7× 181 0.8× 25 0.2× 47 0.3× 21 1.1k
Ian T. Nisbet Australia 10 167 0.3× 192 0.7× 92 0.4× 52 0.3× 46 0.3× 15 655
H J Thiel Germany 13 278 0.5× 77 0.3× 92 0.4× 23 0.1× 53 0.4× 17 990
Andrew Varble United States 17 341 0.6× 682 2.5× 315 1.4× 15 0.1× 140 1.0× 20 1.1k
Christian Tasca France 15 52 0.1× 244 0.9× 79 0.4× 34 0.2× 155 1.1× 25 867

Countries citing papers authored by John Staczek

Since Specialization
Citations

This map shows the geographic impact of John Staczek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Staczek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Staczek more than expected).

Fields of papers citing papers by John Staczek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Staczek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Staczek. The network helps show where John Staczek may publish in the future.

Co-authorship network of co-authors of John Staczek

This figure shows the co-authorship network connecting the top 25 collaborators of John Staczek. A scholar is included among the top collaborators of John Staczek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Staczek. John Staczek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Staczek, John, Linda B. Gilleland, Henri C. van der Heyde, & H. E. Gilleland. (2003). DNA vaccines against chronic lung infections byPseudomonas aeruginosa. FEMS Immunology & Medical Microbiology. 37(2-3). 147–153. 16 indexed citations
2.
Legutki, Joseph Barten, et al.. (2002). Enhancement of the protective efficacy of anoprFDNA vaccine againstPseudomonas aeruginosa. FEMS Immunology & Medical Microbiology. 33(2). 89–99. 29 indexed citations
3.
Galloway, Darrell R., et al.. (2001). Protection againstPseudomonas aeruginosaChronic Lung Infection in Mice by Genetic Immunization against Outer Membrane Protein F (OprF) ofP. aeruginosa. Infection and Immunity. 69(5). 3510–3515. 52 indexed citations
4.
Gilleland, H. E., Linda B. Gilleland, John Staczek, et al.. (2000). Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine againstPseudomonas aeruginosalung infection. FEMS Immunology & Medical Microbiology. 27(4). 291–297. 45 indexed citations
5.
Staczek, John, Mohammed Bendahmane, Linda B. Gilleland, Roger N. Beachy, & H. E. Gilleland. (2000). Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P. aeruginosa. Vaccine. 18(21). 2266–2274. 64 indexed citations
6.
Staczek, John, et al.. (1998). Low-Frequency Electromagnetic Fields Alter the Replication Cycle of MS2 Bacteriophage. Current Microbiology. 36(5). 298–301. 6 indexed citations
7.
8.
Gilleland, H. E., et al.. (1995). Use of synthetic peptides to identify surface-exposed, linear B-cell epitopes within outer membrane protein F of Pseudomonas aeruginosa. Current Microbiology. 31(5). 279–286. 27 indexed citations
9.
Raengsakulrach, Boonyos & John Staczek. (1992). Analysis of immediate-early transcripts of equine cytomegalovirus. Virology. 186(2). 496–506. 3 indexed citations
10.
Gray, Wayne L., Ramana R. Yalamanchili, Boonyos Raengsakulrach, et al.. (1989). Viral transcripts in cells infected with defective interfering particles of equine herpesvirus type 1. Virology. 172(1). 1–10. 18 indexed citations
11.
Colacino, Joseph M., et al.. (1989). Physical structure and molecular cloning of equine cytomegalovirus DNA. Virology. 173(2). 566–580. 12 indexed citations
12.
Robertson, Alice, Gretchen B. Caughman, Wayne L. Gray, et al.. (1988). Analysis of the in vitro translation products of the equine herpesvirus type 1 immediate early mRNA. Virology. 166(2). 451–462. 26 indexed citations
13.
Gray, Wayne L., Raymond P. Baumann, Alice Robertson, et al.. (1987). Regulation of equine herpesvirus type 1 gene expression: Characterization of immediate early, early, and late transcription. Virology. 158(1). 79–87. 85 indexed citations
14.
Gray, Wayne L., Raymond P. Baumann, Alice Robertson, Dennis J. O’Callaghan, & John Staczek. (1987). Characterization and mapping of equine herpesvirus type 1 immediate early, early, and late transcripts. Virus Research. 8(3). 233–244. 67 indexed citations
15.
Baumann, Raymond P., John Staczek, & Dennis J. O’Callaghan. (1987). Equine herpesvirus type 1 defective-interfering (DI) particle DNA structure: The central region of the inverted repeat is deleted from DI DNA. Virology. 159(1). 137–146. 28 indexed citations
16.
Baumann, Raymond P., Donna C. Sullivan, John Staczek, & Dennis J. O’Callaghan. (1986). Genetic relatedness and colinearity of genomes of equine herpesvirus types 1 and 3. Journal of Virology. 57(3). 816–825. 33 indexed citations
17.
Staczek, John, et al.. (1984). Coestablishment of persistent infection and oncogenic transformation of hamster embryo cells by equine cytomegalovirus. Virology. 132(2). 339–351. 8 indexed citations
18.
19.
Sullivan, Donna C., Sally S. Atherton, John Staczek, & Dennis J. O’Callaghan. (1984). Structure of the genome of equine herpesvirus type 3. Virology. 132(2). 352–367. 21 indexed citations
20.
Caughman, Gretchen B., John Staczek, & Dennis J. O’Callaghan. (1984). Equine cytomegalovirus: Structural proteins of virions and nucleocapsids. Virology. 134(1). 184–195. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sylvie Laurent Breakdown of academic impact, for papers by Ruth Serra-Moreno Breakdown of academic impact, for papers by P A Hoyne Breakdown of academic impact, for papers by D. M. A. Evans Breakdown of academic impact, for papers by Ieva Kotlarski Breakdown of academic impact, for papers by Ruth Ann Scroggs Breakdown of academic impact, for papers by Ian T. Nisbet Breakdown of academic impact, for papers by H J Thiel Breakdown of academic impact, for papers by Andrew Varble Breakdown of academic impact, for papers by Christian Tasca
Rankless by CCL
2026